Navigation Links
OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award
Date:4/1/2009

Recognized for Innovative Design, Positive Impact on Lives of People with Insulin-Dependent Diabetes

BEDFORD, Mass., April 1 /PRNewswire-FirstCall/ -- The OmniPod(R) Insulin Management System, designed and produced by Insulet Corporation (Nasdaq: PODD), today won a 2009 Edison Best New Product Award(TM). The product was honored with the Gold Award in the Science and Medical category in recognition of its innovative design that offers people living with insulin-dependent diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes.

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod -- a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager -- a wireless, menu-driven, hand-held device that programs the Pod.

OmniPod user Ethan Alexander of San Francisco, who attended the awards ceremony held in Mountain View, CA, is one such person who benefits from the product's unique features. He was diagnosed with type 1 diabetes in 1999 and initially used conventional insulin pumps to deliver his insulin. "Those pumps weren't right for me because I have an active life that includes surfing and playing soccer," Mr. Alexander said. "The tubing frequently got in the way, keeping me from doing what I wanted."

"OmniPod lets me live my life my way and is the best choice for me. I now can freely engage in all these activities while receiving my insulin, because it has no tubing, is watertight, durable and is always on me. As a professional in the world of technology myself, I appreciate OmniPod's advanced wireless capabilities and diabetes management -- it's truly one of a kind," he added.

Insulet Co-Founder John Garibotto, who played a central role in the OmniPod System's development, further explained what sets it apart: "The Pod is a key part of OmniPod's revolutionary design. It holds the pumping mechanism in a disposable, self-contained device that is worn for up to three days at a time and then replaced. We were able to eliminate the need for tubing by separating the controls and user interface from the insulin delivery mechanism."

The Edison Best New Product Awards, sponsored this year by Google, The Nielsen Company and Steelcase, focus on new products and services that excel in marketplace innovation, marketplace success, technological innovation, market structure innovation, and societal impact. These criteria align with Edison's own innovation best practices, called the Five Competencies of Innovation. Winners were selected by members of the national Marketing Executive Network Group, who cast their ballots for entries they deemed worthy of being linked to the Edison name.

"We are deeply grateful that OmniPod has been honored by the Edison Awards for the positive impact it has on the lives of people with diabetes," said Duane DeSisto, president and CEO of Insulet Corporation. "We created OmniPod from scratch using a customer focused approach. With the input of people living with diabetes, we were able to design a unique, easy-to-use insulin delivery system that allows our customers to get the best treatment and live their lives to the fullest."

For more information on OmniPod, visit www.myomnipod.com.

About The Edison Awards:

The Edison Best New Products Award(TM) honors excellence in new product development, marketing and innovation. They recognize the persistence and excellence Thomas Edison personified, qualities which have allowed America to remain in the forefront of innovation, creativity, and ingenuity in the global economy. The Edison Achievement Award(TM) honors business leaders who have displayed the persistence, collaboration, and creativity necessary to promote successful innovation in their organizations. For more information about The Edison Awards, visit www.edisonawards.com.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contacts:

    Rachel Kessler
    Lazar Partners
    917-660-0608
    rkessler@lazarpartners.com

    Erich Sandoval
    Lazar Partners
    917-497-2867
    esandoval@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
2. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
3. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
4. NICE SUGAR: Intensive insulin therapy risks
5. Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan
6. Gene Explains How High-Fructose Diets Lead to Insulin Resistance
7. Ethnicity May Drive Response to Obesity, Insulin Resistance
8. Fasting Signal Offers Clues to Insulin Resistance in the Obese
9. Insulin drug study shows significant improvements in more than 52,000 diabetic patients
10. Ethnic differences found for fatty liver disease and insulin resistance
11. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: